Changes

Quote





Correction, Mr. H was promoted. I believe it was his 7th promotion in 18 months. Hardly what I would call a failure. It does get cut throat at the top and HQ is loaded with snakes.
 








These posts are what is wrong with JnJ. It makes me ashamed to have ever worked for such a classless operation. There is a reason JnJ is always on the industry bottom. I will enjoy sticking it to you.
 


The thing to do is make this what you want it to be. If you want big money get a side gig since the payday here is well over. The point being use this job like this company uses you. They never promised you anything more than a pay check and a role that leaves you unfulfilled. Everything else is up to you.
 


Anonymous said:
H Promoted? Did you see the title? Puhleeeease. Step Aside little man. Make room for a real marketer like JoeV.
Click to expand...

The bloom is off the V Rose. Seems there's been some dipping of the personal pen in the company ink, and apparently (who knew?!) that kind of behavior is frowned upon. MY can't save him.
 


It does not matter at JnJ. If it did you would have a new CEO and about 1,000 executives would be done. These shameless fools have been "dipping" into the company ink for a very long time. They view it as a right of their position. The dipping is the least of the issues in front of JnJ.

I believe that the JBI umbrella has gone so far sideways that it is beyond repair. It would be a good time to break this into pieces and spread it to other OpCos. Start by dumping the GI and RA divisions that won't be able to hold their own when Infliximab goes off patent. Seven (yes seven) biologic simulars have filed with the FDA for manufacturing and/or importing of the same starting 2017. Any group selling this product should be sold while a price can be had. In two years you won't be able to give immunology away. Maintain the Derm rights as Ustakinumab is doing well and will remain profitable. Onc is betting on the pipeline for survival but based on history could be a keeper.
If I sound like a market analyst it is because I am. This is my biz. I recommend your organization focuses on what you do and not what you did. Infliximab paid for the party but new coin is needed for the band to keep playing. So far passing the hat around has not been effective.
If this poor level of results and under market production continues not even B Hathaway holding will be able to protect your pending fall. I still recommend JnJ as moderate buys and short line but a hit could be coming with if the industry miscalculations continues. At the head or at the tail, the fall will happen either way.
 






V's arrogance is catching up with him. Not making his number and his personal reputation is a mess. But when he's walking around Horsham, he still thinks he's the man. Kind of sad. But not really. Karma
 






For your info: Company under a CIA have legal right to obtain any and all information related to its sales and marketing practices and personnel. That means JBI has had all info on threads for some time. If you feel targeted that might be why. If you notice nobody places info here anymore. You might want to get a cat or dog and whine to that as your career would be better served. No doubt to late for a JNJ one.
 


People don't post here cause 99% is BS and all the clever people have left. Only tyrants here now. JBI has nuthin' never did never will. CIA? WTF? Doesn't matter. CP don't store it. Posts are anonymous. Besides who has a static IP address? So you can trace my post all the way to Lima? Great what does that get you if I'm in NYC? If you are feeling targeted, it's because you are tenured and they want you gone by any means. A blind RD could see it. We don't need CP to get rid of you, everything is already in place. Changes are in the works. Sorry legs ya shoulda jumped when ya could.
 



Write your reply...
Top Bottom
Back
Quote